Response Genetics, Inc. (RGDX) Reports Wider Q2 Loss of $0.08/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. UNH
7. CVS
8. SBUX
9. AXP
10. ZETA

Go back to Response Genetics, Inc. (RGDX) Reports Wider Q2 Loss of $0.08/Share

Response Genetics, Inc. Announces Second Quarter 2014 Financial Results

August 14, 2014 7:00 AM EDT

LOS ANGELES, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq: RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced its consolidated financial results and business progress for the second quarter ended June 30, 2014.

Second Quarter 2014 Highlights:

Record ResponseDX® revenues increase 18% over Q2 2013 and 11% over Q1 2014 Volume increases 16% over Q1 2014 Gross margins increase to 40% Operating loss decreases 11% from Q1 2014

Total revenue for the second quarter ended June 30, 2014 was $4.3 million compared to... More